Interestingly, our data revealed a CDH4 variant (rs2427043) with a potential impact on the progression of tumours in the HCC population, reflecting an increased risk of downregulated expression of the CDH4 protein. The gene discussed is CDH4; the disease is hepatocellular carcinoma.